🇺🇸 OMVOH in United States

FDA authorised OMVOH on 26 October 2023

Marketing authorisation

FDA — authorised 26 October 2023

  • Application: BLA761279
  • Marketing authorisation holder: ELI LILLY AND CO
  • Local brand name: OMVOH
  • Indication: VIAL — SINGLE-USE
  • Status: approved

The FDA approved OMVOH, a drug developed by ELI LILLY AND CO, on 2024-04-29. The approval was granted under the standard expedited pathway. The marketing authorisation holder is ELI LILLY AND CO, and the indication approved is for labeling.

Read official source →

OMVOH in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is OMVOH approved in United States?

Yes. FDA authorised it on 26 October 2023.

Who is the marketing authorisation holder for OMVOH in United States?

ELI LILLY AND CO holds the US marketing authorisation.